|
PHF14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.30769999776115E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.2621999996626E-07 |
| Normal-vs-Stage2 |
5.84339999999406E-05 |
| Normal-vs-Stage3 |
4.94400076433976E-11 |
| Normal-vs-Stage4 |
8.140600005202E-08 |
| Stage1-vs-Stage2 |
8.191600E-01 |
| Stage1-vs-Stage3 |
2.322500E-03 |
| Stage1-vs-Stage4 |
9.109900E-02 |
| Stage2-vs-Stage3 |
4.292100E-02 |
| Stage2-vs-Stage4 |
2.014000E-01 |
| Stage3-vs-Stage4 |
5.445000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.91520000151158E-08 |
| Normal-vs-AfricanAmerican |
1.018570E-03 |
| Normal-vs-Asian |
6.1436999999942E-05 |
| Caucasian-vs-AfricanAmerican |
8.309800E-01 |
| Caucasian-vs-Asian |
5.882800E-01 |
| AfricanAmerican-vs-Asian |
8.642800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.84039999976349E-07 |
| Normal-vs-Female |
3.38100000218944E-08 |
| Male-vs-Female |
9.851400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.33310000003129E-06 |
| Normal-vs-Age(41-60Yrs) |
3.70149999540104E-08 |
| Normal-vs-Age(61-80Yrs) |
6.36620000049604E-08 |
| Normal-vs-Age(81-100Yrs) |
6.796200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.200000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.096370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.630000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.409400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.622800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.600600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.82309999999487E-05 |
| Classical-VS-Follicular |
4.386400E-01 |
| Classical-VS-Other |
7.973200E-01 |
| Classical-VS-Normal |
7.45489999953719E-07 |
| Tall-VS-Follicular |
4.557400E-03 |
| Tall-VS-Other |
4.435600E-01 |
| Tall-VS-Normal |
2.68350008880702E-10 |
| Follicular-VS-Other |
8.991000E-01 |
| Follicular-VS-Normal |
1.93942999999752E-05 |
| Other-VS-Normal |
1.709590E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.38139999994458E-07 |
| Normal-vs-N1 |
2.29150000086165E-08 |
| N0-vs-N1 |
1.179810E-01 |
|
|
